Analyst forecasts provide a strategic view of future market potential beyond headline numbers. This analysis highlights ten Nifty500 stocks identified using consensus estimates from Trendlyne, focusing on companies with sequential earnings growth, multi-analyst coverage, and strong upside potential over the next 12 months.
Dr Reddy’s shares slide 7% after delay in semaglutide supplies over quality concerns
Dr Reddy’s shares fell sharply on Thursday after the company delayed commercial supplies of its semaglutide product due to a quality issue involving the active